Clinical Trials Browser

OTHER × Breast Neoplasms × Risedronic Acid × Clear all

NCT00485953 2017-10-13

REBBeCA II

Phase 4 Completed

109 enrolled 11 charts

Bone Diseases, Metabolic, Breast Neoplasms, Osteoporosis

NCT00054418 2016-07-13

Risedronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy for Primary Breast Cancer

Phase 3 Completed

Breast Neoplasms, Osteoporosis

NCT00859703 2013-10-31

RISAROS

Phase 3 Completed

Bone Diseases, Metabolic, Breast Neoplasms, Osteoporosis